Bellicum Pharmaceuticals gene-modified donor T-cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Bellicum Pharmaceuticals gene-modified donor T-cells, covering 2022-07-12 to 2024-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases [Phase 1]